Gujarat Themis Biosyn informs about outcome of board meeting

03 Feb 2023 Evaluate
Gujarat Themis Biosyn has informed that the Board of Directors at its meeting held today, considered and approved the Unaudited Financial Results of the Company for the Quarter ended 31st December, 2022. A copy of Unaudited Financial Results of the Company for the Quarter ended 31st December, 2022 together with Limited Review Report is enclosed.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

407.35 11.90 (3.01%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.